Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
The University of Texas Health Science Center at San Antonio
The University of Texas Health Science Center at San Antonio
Baylor College of Medicine
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
Pfizer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Takeda
Ocellaris Pharma, Inc.
Novartis
University Hospital, Lille
Blueprint Medicines Corporation
Elevation Oncology
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Actym Therapeutics, Inc.
Amgen
Leap Therapeutics, Inc.
Taiho Oncology, Inc.
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Sanofi
Pfizer
3B Pharmaceuticals GmbH
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Cancer Trials Ireland
Fudan University
Pfizer
Imugene Limited
Hutchmed
Fondazione IRCCS Policlinico San Matteo di Pavia
Black Diamond Therapeutics, Inc.
Kymab Limited
Mayo Clinic
Seagen Inc.
Seagen Inc.
Seagen Inc.
Alliance for Clinical Trials in Oncology
Pfizer
Aminex Therapeutics, Inc.
Celularity Incorporated
Peking University Cancer Hospital & Institute
Highlight Therapeutics
Hoffmann-La Roche
Ukrainian Society of Clinical Oncology
Huazhong University of Science and Technology
Shanghai PerHum Therapeutics Co., Ltd.
Inhibrx Biosciences, Inc
Rain Oncology Inc
BioNTech SE